These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2889957)

  • 1. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment.
    van Holten-Verzantvoort AT; Bijvoet OL; Cleton FJ; Hermans J; Kroon HM; Harinck HI; Vermey P; Elte JW; Neijt JP; Beex LV
    Lancet; 1987 Oct; 2(8566):983-5. PubMed ID: 2889957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.
    Lipton A; Theriault RL; Hortobagyi GN; Simeone J; Knight RD; Mellars K; Reitsma DJ; Heffernan M; Seaman JJ
    Cancer; 2000 Mar; 88(5):1082-90. PubMed ID: 10699899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term bisphosphonate treatment on morbidity due to bone metastases in breast cancer patients.
    Cleton FJ; van Holten-Verzantvoort AT; Bijvoet OL
    Recent Results Cancer Res; 1989; 116():73-8. PubMed ID: 2669067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tumor-induced osteolysis by APD.
    Burckhardt P; Thiébaud D; Perey L; von Fliedner V
    Recent Results Cancer Res; 1989; 116():54-66. PubMed ID: 2762665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
    Dodwell DJ; Howell A; Ford J
    Br J Cancer; 1990 Jan; 61(1):123-5. PubMed ID: 2297483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
    Coleman RE; Rubens RD
    Br J Cancer; 1987 Oct; 56(4):465-9. PubMed ID: 3689664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative pamidronate treatment in patients with bone metastases from breast cancer.
    van Holten-Verzantvoort AT; Kroon HM; Bijvoet OL; Cleton FJ; Beex LV; Blijham G; Hermans J; Neijt JP; Papapoulos SE; Sleeboom HP
    J Clin Oncol; 1993 Mar; 11(3):491-8. PubMed ID: 7680374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pamidronate in the treatment of bone metastases from breast cancer].
    Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
    Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
    Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
    Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteolytic metastases of breast cancer and biphosphonates].
    Lortholary A; Alleaume C; Pein F; Larra F
    Rev Med Interne; 1992; 13(3):238-42. PubMed ID: 1410908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer.
    van Holten-Verzantvoort AT; Zwinderman AH; Aaronson NK; Hermans J; van Emmerik B; van Dam FS; van den Bos B; Bijvoet OL; Cleton FJ
    Eur J Cancer; 1991; 27(5):544-9. PubMed ID: 1675865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Coleman RE; Woll PJ; Miles M; Scrivener W; Rubens RD
    Br J Cancer; 1988 Nov; 58(5):621-5. PubMed ID: 3219273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.
    Conte PF; Giannessi PG; Latreille J; Mauriac L; Koliren L; Calabresi F; Ford JM
    Ann Oncol; 1994; 5 Suppl 7():S41-4. PubMed ID: 7873461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer.
    van Holten-Verzantvoort AT; Papapoulos SE
    Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
    Morton AR; Cantrill JA; Pillai GV; McMahon A; Anderson DC; Howell A
    BMJ; 1988 Sep; 297(6651):772-3. PubMed ID: 3142542
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Lipton A; Porter L; Blayney D; Sinoff C; Wheeler H; Simeone JF; Seaman JJ; Knight RD; Heffernan M; Mellars K; Reitsma DJ
    J Clin Oncol; 1998 Jun; 16(6):2038-44. PubMed ID: 9626201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer.
    Coleman RE; Houston S; Purohit OP; Rubens RD; Kandra A; Ford J
    Eur J Cancer; 1998 May; 34(6):820-4. PubMed ID: 9797692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.